Tocriscreen Kinase Inhibitor 3.0

Cat. No. 7844 17 篇引用文献提交评论说明书 / 分析证书（CoA） / 化学品安全技术说明书（SDS）

Pricing	Availability		Qty

说明： A bioactive compound library of 210 kinase inhibitors (100 μL 10 mM DMSO solutions) for high-throughput screening, high-content screening, target validation and assay development

引用文献 (17)

文献 (1)

生物活性 Scientific Data 技术数据说明书参考文献

生物活性 for Tocriscreen Kinase Inhibitor 3.0

Tocriscreen Kinase Inhibitor 3.0 compound library is a collection of 210 kinase inhibitors supplied pre-dissolved in DMSO (100 μL 10 mM solution). The Tocriscreen Kinase Inhibitor 3.0 Library contains compounds targeting >60 different kinases, including extensive coverage of well-established targets such as VEFGR and AKT, as well as novel targets such as Haspin and DYRK. The Tocriscreen Kinase Inhibitor 3.0 library is suitable for high-throughput screening (HTS), cell based high-content screening (HCS), target validation and assay development. Please view the kinase tree image for a closer look at the pharmacological diversity of this compound library.

If this library does not suit your needs, please submit your requirements through our Tocriscreen PRO custom compound library service.

Scientific Data

View Larger

Kinase phylogenetic tree illustrating the pharmacological diversity of the Tocriscreen Kinase Inhibitor 3.0 Library. The 210 compounds in the Tocriscreen Kinase Inhibitor 3.0 compound library target over 230 kinases. Targets are evenly spread across all the major IUPHAR kinase subfamilies, with a mix of well-established targets such as VEFGR and AKT, and “dark” kinases such as CDK19 and DYRK1B. To view a larger PDF version of this image, please click on the 'kinase tree' link in the product description.

View Larger

Chemical diversity of the Tocriscreen Kinase Inhibitor 3.0 compound library. The images show the overlapping chemical space of the 210 compounds in the Tocriscreen Kinase Inhibitor 3.0 compound library (green dots) in relation to the chemical space occupied by the ChEMBL kinase inhibitors (grey dots). Each dot represents a unique fingerprint generated from each compound's 3D molecular structure. The even distribution of the fingerprints of the compounds in the Tocriscreen Kinase Inhibitor 3.0 compound library highlights the chemical diversity of this library.

Key Format and Product Details for Tocriscreen Kinase Inhibitor 3.0

96-well racks with TrakMate tubes & SepraSeal caps
Pre-dissolved in DMSO
Compounds arranged 80 per rack with 3 racks per library

Many compounds are exclusive to Tocris
Full chemical and biological data available
Exceptional purity

Kinase subfamilies targeted by the Tocriscreen Kinase Inhibitor 3.0 library

Major IUPHAR kinase subfamilies covered by Tocriscreen Kinase Inhibitor 3.0 Library. TK (tyrosine kinase, 29%); CMGC (includes CDK, MAPK, GSK3 and CLK families, 19%); TKL (tyrosine kinase-like, 16%); AGC (includes PKA, PKG and PKC families, 11%); Atypical (7%); CAMK, (calcium/calmodulin-dependent protein kinases, 4%) and Other Kinases (includes CAMKK, CK1 and STE, 14%).

索取化合物列表

如需索取 Tocriscreen Kinase Inhibitor 3.0 中包含的化合物列表，请点击下方的索取图块。化合物列表以 Excel 或 SD 格式提供。

索取化合物列表： Tocriscreen Kinase Inhibitor 3.0

技术数据 for Tocriscreen Kinase Inhibitor 3.0

储存	Store at -20°C

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for Tocriscreen Kinase Inhibitor 3.0

分析证书目前不在网上提供。
请联系客户服务

化学品安全技术说明书

参考文献 for Tocriscreen Kinase Inhibitor 3.0

参考文献是支持产品生物活性的出版物。

If you know of a relevant reference for Tocriscreen Kinase Inhibitor 3.0, please let us know.

按标靶查看相关产品

Tocriscreen™ Compound Libraries

关键词: Tocriscreen Kinase Inhibitor 3.0, Tocriscreen Kinase Inhibitor 3.0 supplier, tocriscreen, kinase, inhibitor, library, kinases, toolbox, inhibitors, inhibits, compound, libraries, high-throughput, screening, high-content, chemical, biology, applications, Tocriscreen, Compound, Libraries, 7844, Tocris Bioscience

17 篇 Tocriscreen Kinase Inhibitor 3.0 的引用文献

引用文献是使用了 Tocris 产品的出版物。 Tocriscreen Kinase Inhibitor 3.0 的部分引用包括：

Gilles et al (2021) Developments in the discovery and design of protein kinase D inhibitors. Chem.Med.Chem. 16 2158 PMID: 33829655

Wang et al (2019) EGFR-Aurka signaling rescues polarity and regeneration defects in dystrophin-deficient muscle stem cells by increasing asymmetric divisions. Cell Stem Cell 24 419 PMID: 30713094

Moret et al (2019) Cheminformatics tools for analyzing and designing optimized small-molecule collections and libraries. Cell Chem Biol 26 765 PMID: 30956147

Chaudhari et al (2019) Transient c-Src Suppression During Endodermal Commitment of Human Induced Pluripotent Stem Cells Results in Abnormal Profibrotic Cholangiocyte-Like Cells. Stem Cells 37 306 PMID: 30471152

Yang et al (2019) NTRK1 is a positive regulator of YAP oncogenic function. Oncogene 38 2778 PMID: 30542115

Gull et al (2022) Screening of chemical libraries using xenopus embryos and tadpoles for phenotypic drug discovery. Cold Spring Harb.Protoc. 4 PMID: 36180216

Carlson et al (2022) Discovery and characterization of multiple classes of human CatSper blockers. Chem Med Chem 17 e202000499 PMID: 35644882

Haga et al (2024) Positive and negative feedback regulation of the TGF-β1 explains two equilibrium states in skin aging. iScience 27 109708 PMID: 38706856

Mudaliar et al (2024) Discovery of a CK2α'-biased ATP-competitive inhibitor from a high-throughput screen of an allosteric-inhibitor-like compound library. ACS Chem.Neurosci. PMID: 38908003

Orlando et al (2023) Chemical genomics reveals targetable programs of human cancers rooted in pluripotency. Cell Chem.Biol. 30 780 PMID: 37379846

Hewage et al (2020) Chemical manipulation of abscisic acid signaling: a new approach to abiotic and biotic stress management in agriculture. Adv.Sci. 7 2001265 PMID: 32999840

Lee et al (2021) A screen of kinase inhibitors reveals a potential role of Chk1 in regulating Hydra head regeneration and maintenance. Int J Dev Biol 65 523 PMID: 34549798

Jacoby et al (2018) Protocols for the design of kinase-focused compound libraries. Mol.Inform. 37 e1700119 PMID: 29116686

Azad et al (2018) A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun 9 1061 PMID: 29535383

Moeschler et al (2018) 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. Viruses 10 E306 PMID: 29874821

Tomilov et al (2018) Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition. Pharmacol Res 137 89 PMID: 30290222

Markussen et al (2018) GSK3 is a negative regulator of the thermogenic program in brown adipocytes. Sci.Rep. 8 3469 PMID: 29472592

您是否知道使用了 Tocris Tocriscreen Kinase Inhibitor 3.0 的优秀论文？请告知我们.